Hera Biotech: Precision Diagnostics for Endometriosis and Women's Health | Stories in Life Sciences

For decades, women's health has been under-researched, underfunded, and underserved. In this episode of Stories in Life Sciences by MedAxis AI, Christopher Wilson sits down with Somer Barburek, CEO and Co-founder of Hera Biotech, to explore how precision diagnostics and molecular innovation are starting to change that.Somer's path to biotech founder ran through professional rodeo athletics and a firsthand understanding of how little the healthcare system was built around women's biology. At Hera Biotech, she's building a platform that uses molecular and machine-learning diagnostics to detect endometriosis earlier and more accurately, replacing invasive surgery with simple, office-based testing.In this episode of Stories in Life Sciences, we cover:Why women's health has been historically underfunded and what that means for patients todayHow Hera Biotech is tackling endometriosis with molecular and AI-driven diagnosticsThe shift from invasive surgical diagnosis to office-based precision testingSomer's journey from professional rodeo athlete to biotech founderThe realities of biotech commercialization and scaling a women's health companyWhat a more equitable, data-driven future in medicine actually looks likeWho this is for: founders, clinicians, investors, and researchers in women's health, biotech diagnostics, medtech, and digital health who want to understand where precision medicine for women is headed.Guest: Somer Barburek, CEO and Co-founder, Hera Biotech www.herabiotech.com https://www.linkedin.com/company/hera-biotechHost:Chistopher Wilson, Founder, MedAxis AIwww.medaxisai.orghttps://www.linkedin.com/in/christopher-wilson-medaxisai https://www.linkedin.com/company/medaxisaiFollow Stories in Life Sciences on Spotify, Apple Podcasts, and YouTube for new episodes.